Deferred Tax Assets, Valuation Allowance in USD of OptimizeRx Corp from Q4 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
OptimizeRx Corp quarterly Deferred Tax Assets, Valuation Allowance history and change rate from Q4 2011 to Q3 2025.
  • OptimizeRx Corp Deferred Tax Assets, Valuation Allowance for the quarter ending 30 Sep 2025 was $1.9M.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

OptimizeRx Corp Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $1.9M 30 Sep 2025 10-Q 07 Nov 2025
Q2 2025 $2.9M 30 Jun 2025 10-Q 08 Aug 2025
Q1 2025 $2.9M 31 Mar 2025 10-Q 13 May 2025
Q4 2024 $4.22M +$864K +25.7% 31 Dec 2024 10-K 20 Mar 2025
Q4 2023 $3.36M -$4.81M -58.9% 31 Dec 2023 10-K 20 Mar 2025
Q4 2022 $8.16M +$2.9M +55.1% 31 Dec 2022 10-K 15 Apr 2024
Q4 2021 $5.26M +$3.01M +133% 31 Dec 2021 10-K 10 Mar 2023
Q4 2020 $2.26M +$529K +30.6% 31 Dec 2020 10-K/A 10 Mar 2023
Q4 2019 $1.73M -$1.21M -41.2% 31 Dec 2019 10-K 08 Mar 2021
Q4 2018 $2.94M -$83K -2.75% 31 Dec 2018 10-K 26 Mar 2020
Q4 2017 $3.02M -$1.17M -27.8% 31 Dec 2017 10-K 12 Mar 2019
Q4 2016 $4.19M +$1.08M +34.6% 31 Dec 2016 10-K 08 Mar 2018
Q4 2015 $3.11M -$16K -0.51% 31 Dec 2015 10-K 08 Mar 2017
Q4 2014 $3.13M +$333K +11.9% 31 Dec 2014 10-K 15 Mar 2016
Q1 2014 $5M +$9.74M 31 Mar 2014 10-Q 15 May 2014
Q4 2013 $2.79M +$7.53M 31 Dec 2013 10-K 16 Sep 2015
Q3 2013 -$4.62M +$129K +2.72% 30 Sep 2013 10-Q 14 Nov 2013
Q2 2013 -$4.62M +$89K +1.89% 30 Jun 2013 10-Q 12 Aug 2013
Q1 2013 -$4.74M 31 Mar 2013 10-Q 15 May 2013
Q4 2012 -$4.74M -$155K -3.38% 31 Dec 2012 10-K 31 Mar 2014
Q3 2012 -$4.75M 30 Sep 2012 10-Q 14 Nov 2012
Q2 2012 -$4.71M 30 Jun 2012 10-Q 14 Aug 2012
Q4 2011 -$4.58M 31 Dec 2011 10-K 12 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.